Thiopurine‐S‐methyltransferase genotype and the response to azathioprine in inflammatory bowel disease
暂无分享,去创建一个
[1] W. Evans,et al. Using HapMap Tools in Pharmacogenomic Discovery: The Thiopurine Methyltransferase Polymorphism , 2007, Clinical pharmacology and therapeutics.
[2] D. Gaffney,et al. Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease , 2007, Alimentary pharmacology & therapeutics.
[3] U. Klotz,et al. Thiopurine Treatment in Inflammatory Bowel Disease , 2007, Clinical pharmacokinetics.
[4] U. Klotz,et al. Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing. , 2007, Clinical pharmacokinetics.
[5] P. Lionetti,et al. TPMT genotype and the use of thiopurines in paediatric inflammatory bowel disease. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[6] N. D. de Boer,et al. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[7] G. Lichtenstein,et al. Review article: monitoring of immunomodulators in inflammatory bowel disease , 2005, Alimentary pharmacology & therapeutics.
[8] S. Cucchiara,et al. Azathioprine in paediatric inflammatory bowel disease: an Italian multicentre survey , 2002, Alimentary pharmacology & therapeutics.
[9] J. Markowitz,et al. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. , 2000, Gastroenterology.
[10] R. Boulieu,et al. Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC. , 1998, Clinical chemistry.